Brief: Lee's Pharmaceutical Holdings Says Unit Successfully Completed Phase II Trial Of Cyclosporine A Ophthalmic Gel In China
30/10/2019 14:17
Oct 30 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UNIT SUCCESSFULLY COMPLETED A PHASE II TRIAL OF
CYCLOSPORINE A
(CSA) OPHTHALMIC GEL IN CHINA
* TOPLINE DATA SHOW EXPERIMENTAL DRUG HAS SIMILAR OR A TREND
TOWARDS BETTER EFFICACY THAN THAT OF MARKETED CSA OPHTHALMIC
EMULSION
* PLANS TO MEET WITH CENTER FOR DRUG EVALUATION IN CHINA TO
DISCUSS AND AGREE UPON A PHASE III PROTOCOL OF CSA OPHTHALMIC
GEL TRIAL
* PHASE III STUDY IS EXPECTED TO INITIATE PATIENT
RECRUITMENT IN
EARLY 2020
Source text for Eikon: ID:nHKSb3llfW
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA